Literature DB >> 26078002

Quantitative Correlation between Viscosity of Concentrated MAb Solutions and Particle Size Parameters Obtained from Small-Angle X-ray Scattering.

Masakazu Fukuda1, Chifumi Moriyama2, Tadao Yamazaki2, Yoshimi Imaeda2, Akiko Koga2.   

Abstract

PURPOSE: To investigate the relationship between viscosity of concentrated MAb solutions and particle size parameters obtained from small-angle X-ray scattering (SAXS).
METHODS: The viscosity of three MAb solutions (MAb1, MAb2, and MAb3; 40-200 mg/mL) was measured by electromagnetically spinning viscometer. The protein interactions of MAb solutions (at 60 mg/mL) was evaluated by SAXS. The phase behavior of 60 mg/mL MAb solutions in a low-salt buffer was observed after 1 week storage at 25°C.
RESULTS: The MAb1 solutions exhibited the highest viscosity among the three MAbs in the buffer containing 50 mM NaCl. Viscosity of MAb1 solutions decreased with increasing temperature, increasing salt concentration, and addition of amino acids. Viscosity of MAb1 solutions was lowest in the buffer containing histidine, arginine, and aspartic acid. Particle size parameters obtained from SAXS measurements correlated very well with the viscosity of MAb solutions at 200 mg/mL. MAb1 exhibited liquid-liquid phase separation at a low salt concentration.
CONCLUSIONS: Simultaneous addition of basic and acidic amino acids effectively suppressed intermolecular attractive interactions and decreased viscosity of MAb1 solutions. SAXS can be performed using a small volume of samples; therefore, the particle size parameters obtained from SAXS at intermediate protein concentration could be used to screen for low viscosity antibodies in the early development stage.

Entities:  

Keywords:  MAb; SAXS; Viscosity

Mesh:

Substances:

Year:  2015        PMID: 26078002     DOI: 10.1007/s11095-015-1739-6

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  24 in total

Review 1.  Challenges in the development of high protein concentration formulations.

Authors:  Steven J Shire; Zahra Shahrokh; Jun Liu
Journal:  J Pharm Sci       Date:  2004-06       Impact factor: 3.534

2.  High concentration formulation studies of an IgG2 antibody using small angle X-ray scattering.

Authors:  Charlotte Rode Mosbæk; Petr V Konarev; Dmitri I Svergun; Christian Rischel; Bente Vestergaard
Journal:  Pharm Res       Date:  2012-04-03       Impact factor: 4.200

3.  Potential inaccurate quantitation and sizing of protein aggregates by size exclusion chromatography: essential need to use orthogonal methods to assure the quality of therapeutic protein products.

Authors:  John F Carpenter; Theodore W Randolph; Wim Jiskoot; Daan J A Crommelin; C Russell Middaugh; Gerhard Winter
Journal:  J Pharm Sci       Date:  2010-05       Impact factor: 3.534

4.  Cluster-driven dynamical arrest in concentrated lysozyme solutions.

Authors:  Frédéric Cardinaux; Emanuela Zaccarelli; Anna Stradner; Saskia Bucciarelli; Bela Farago; Stefan U Egelhaaf; Francesco Sciortino; Peter Schurtenberger
Journal:  J Phys Chem B       Date:  2011-04-29       Impact factor: 2.991

5.  Behavior of monoclonal antibodies: relation between the second virial coefficient (B (2)) at low concentrations and aggregation propensity and viscosity at high concentrations.

Authors:  Shuntaro Saito; Jun Hasegawa; Naoki Kobayashi; Naoyuki Kishi; Susumu Uchiyama; Kiichi Fukui
Journal:  Pharm Res       Date:  2011-08-19       Impact factor: 4.200

6.  Weak interactions govern the viscosity of concentrated antibody solutions: high-throughput analysis using the diffusion interaction parameter.

Authors:  Brian D Connolly; Chris Petry; Sandeep Yadav; Barthélemy Demeule; Natalie Ciaccio; Jamie M R Moore; Steven J Shire; Yatin R Gokarn
Journal:  Biophys J       Date:  2012-07-03       Impact factor: 4.033

7.  Influence of the cosolute environment on IgG solution structure analyzed by small-angle X-ray scattering.

Authors:  Wayne G Lilyestrom; Steven J Shire; Thomas M Scherer
Journal:  J Phys Chem B       Date:  2012-08-03       Impact factor: 2.991

8.  Understanding the synergistic effect of arginine and glutamic acid mixtures on protein solubility.

Authors:  Diwakar Shukla; Bernhardt L Trout
Journal:  J Phys Chem B       Date:  2011-09-27       Impact factor: 2.991

9.  Understanding and modulating opalescence and viscosity in a monoclonal antibody formulation.

Authors:  Branden A Salinas; Hasige A Sathish; Steven M Bishop; Nick Harn; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2010-01       Impact factor: 3.534

10.  Small-angle x-ray scattering screening complements conventional biophysical analysis: comparative structural and biophysical analysis of monoclonal antibodies IgG1, IgG2, and IgG4.

Authors:  Xinsheng Tian; Annette E Langkilde; Matthias Thorolfsson; Hanne B Rasmussen; Bente Vestergaard
Journal:  J Pharm Sci       Date:  2014-04-02       Impact factor: 3.534

View more
  5 in total

1.  Contrasting the Influence of Cationic Amino Acids on the Viscosity and Stability of a Highly Concentrated Monoclonal Antibody.

Authors:  Barton J Dear; Jessica J Hung; Thomas M Truskett; Keith P Johnston
Journal:  Pharm Res       Date:  2016-11-11       Impact factor: 4.200

Review 2.  Viscosity Control of Protein Solution by Small Solutes: A Review.

Authors:  Taehun Hong; Kazuki Iwashita; Kentaro Shiraki
Journal:  Curr Protein Pept Sci       Date:  2018       Impact factor: 3.272

3.  Comparison of Huggins Coefficients and Osmotic Second Virial Coefficients of Buffered Solutions of Monoclonal Antibodies.

Authors:  Jai A Pathak; Sean Nugent; Michael F. Bender; Christopher J Roberts; Robin J Curtis; Jack F Douglas
Journal:  Polymers (Basel)       Date:  2021-02-17       Impact factor: 4.329

4.  Utility of High Resolution 2D NMR Fingerprinting in Assessing Viscosity of Therapeutic Monoclonal Antibodies.

Authors:  Subhabrata Majumder; Deep S Bhattacharya; Alex Langford; Arun Alphonse Ignatius
Journal:  Pharm Res       Date:  2022-02-16       Impact factor: 4.580

5.  A General Small-Angle X-ray Scattering-Based Screening Protocol for Studying Physical Stability of Protein Formulations.

Authors:  Fangrong Zhang; Gesa Richter; Benjamin Bourgeois; Emil Spreitzer; Armin Moser; Andreas Keilbach; Petra Kotnik; Tobias Madl
Journal:  Pharmaceutics       Date:  2021-12-28       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.